Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stagnation in Achieving Recommended Methadone Doses in Opioid Use Disorder Treatment.

Health services research·2026
Same author

Health System Community Partnership to Design an Online Resource to Address Perinatal Information Needs for Black Families: Action Research Study.

JMIR pediatrics and parenting·2026
Same author

Racial Differences in Urinary Incontinence Factors Among Community-dwelling Adults.

Urology·2026
Same author

The role of opioid treatment programs' crisis response on client perceptions of risk and impact.

BMC public health·2025
Same author

Utilizing a Health Equity Framework to Explore Patient-Level Factors Impacting Effective Hypertension Management Across Two Academic Health Systems.

Medical care research and review : MCRR·2025
Same author

A practical framework for appropriate implementation and review of artificial intelligence (FAIR-AI) in healthcare.

NPJ digital medicine·2025
Same journal

The Edge of the Blade: A 21st-Century Commissioned Corps.

Public health reports (Washington, D.C. : 1974)·2026
Same journal

Multimethod Analysis of Potential Disease Intervention Career Pathways at US Undergraduate Institutions.

Public health reports (Washington, D.C. : 1974)·2026
Same journal

Community-Based <i>Helicobacter pylori</i> Screening to Identify Gastric Cancer Risk Among Korean-Born Adults in the United States.

Public health reports (Washington, D.C. : 1974)·2026
Same journal

Corrigendum to "Decline in Fentanyl-Related Overdose Deaths and Subsequent Change in Decedent Demographic Characteristics: Trends in Cuyahoga County, Ohio, 2023-2025".

Public health reports (Washington, D.C. : 1974)·2026
Same journal

Public Awareness and Acceptance of Wastewater Surveillance in the United States, June 2024.

Public health reports (Washington, D.C. : 1974)·2026
Same journal

Experiential and Structural Determinants of Communicable Disease Reporting Among Health Care Providers in Alameda County, California.

Public health reports (Washington, D.C. : 1974)·2026
See all related articles

Related Experiment Video

Updated: Jun 3, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

Trends in prostate-specific antigen test use, 2000-2005.

Louie E Ross1, Yhenneko J Taylor, Daniel L Howard

  • 1Institute for Health, Social and Community Research, Shaw University, Raleigh, NC 27601, USA. rossl@mindspring.com

Public Health Reports (Washington, D.C. : 1974)
|March 11, 2011
PubMed
Summary
This summary is machine-generated.

Prostate-specific antigen (PSA) testing use varied among men aged 40+ from 2000-2005. Factors like chronic disease and family history influenced screening frequency, despite ongoing debates on PSA test efficacy.

More Related Videos

Transperineal Prostate Biopsy Using a Cone-shaped Double-hole Method with Dual-plane Probe Guidance
05:35

Transperineal Prostate Biopsy Using a Cone-shaped Double-hole Method with Dual-plane Probe Guidance

Published on: June 6, 2025

Related Experiment Videos

Last Updated: Jun 3, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

Transperineal Prostate Biopsy Using a Cone-shaped Double-hole Method with Dual-plane Probe Guidance
05:35

Transperineal Prostate Biopsy Using a Cone-shaped Double-hole Method with Dual-plane Probe Guidance

Published on: June 6, 2025

Area of Science:

  • Urology
  • Public Health
  • Health Services Research

Background:

  • Prostate-specific antigen (PSA) testing is a key method for prostate cancer screening.
  • Guidelines on PSA screening efficacy remain debated among major health organizations.
  • Understanding trends in PSA test utilization is crucial for public health initiatives.

Purpose of the Study:

  • To examine prostate-specific antigen (PSA) test use among men aged 40 and older.
  • To identify sociodemographic and health-related factors associated with PSA test use over time.
  • To analyze trends in recent and frequent PSA screening between 2000 and 2005.

Main Methods:

  • Utilized data from 16,058 men aged 40+ from the National Health Interview Survey (2000 and 2005).
  • Assessed two primary outcomes: recent PSA screening (within two years) and frequent PSA testing (three or more tests in five years).
  • Employed unadjusted and adjusted statistical models to identify significant correlates of PSA test use.

Main Results:

  • Recent PSA screening decreased for single men but increased for those with chronic diseases between 2000-2005.
  • Frequent PSA test use increased for men with a family history of prostate cancer, chronic diseases, and recent physician visits.
  • Higher recent PSA test use was associated with older age, marriage, Black race/ethnicity, higher education/income, health insurance, and comorbidity.

Conclusions:

  • Despite lack of consensus on screening efficacy, PSA test utilization persists among men aged 40+.
  • Observed variability in recent and frequent PSA testing has implications for ongoing clinical trials.
  • Further research is needed to clarify the survival benefits of early prostate cancer detection via PSA testing.